Why the study?
Does 2,3-Butanedione monoxime (BDM) improve tolerance to cold ischemia in isolated human myocardial muscle fibers?
Population
Left ventricular human muscle fibers from recipient hearts and right atrial fibers from patients operated…
Comparison
2,3-Butanedione monoxime at concentrations… vs 37°C oxygenated Krebs-Henseleit solution and 4°C…
Design
Preclinical
Authors
Loading...
Should not yet change preservation practices; hypothesis-generating for BDM in human myocardial cold ischemia tolerance.
Does 2,3-Butanedione monoxime (BDM) improve tolerance to cold ischemia in isolated human myocardial muscle fibers?
BDM reversibly desensitizes the myocardial contractile apparatus to calcium, reducing isometric force development in a dose-dependent manner, which may offer a new concept for improving tolerance to cold ischemia in human myocardium.
Vahl et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: